1. Home
  2. FOCL vs ORGO Comparison

FOCL vs ORGO Comparison

Compare FOCL & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo EDAP TMS S.A. American Depositary Shares

FOCL

EDAP TMS S.A. American Depositary Shares

N/A

Current Price

$4.31

Market Cap

203.7M

Sector

Health Care

ML Signal

N/A

Logo Organogenesis Holdings Inc.

ORGO

Organogenesis Holdings Inc.

N/A

Current Price

$1.93

Market Cap

239.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FOCL
ORGO
Founded
N/A
1985
Country
France
United States
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
203.7M
239.3M
IPO Year
1998
2016

Fundamental Metrics

Financial Performance
Metric
FOCL
ORGO
Price
$4.31
$1.93
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$8.50
AVG Volume (30 Days)
174.0K
880.5K
Earning Date
N/A
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
1600.00
EPS
N/A
N/A
Revenue
$70,527,000.00
$564,169,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$26.27
P/E Ratio
N/A
N/A
Revenue Growth
1.63
17.04
52 Week Low
$4.09
$1.54
52 Week High
$6.40
$7.08

Technical Indicators

Market Signals
Indicator
FOCL
ORGO
Relative Strength Index (RSI) 28.05 39.59
Support Level N/A $1.54
Resistance Level $5.64 $2.64
Average True Range (ATR) 0.33 0.13
MACD -0.24 -0.03
Stochastic Oscillator 9.09 40.96

Price Performance

Historical Comparison
FOCL
ORGO

About FOCL EDAP TMS S.A. American Depositary Shares

Edap TMS SA, formerly known as FocalTherics, operates in the Robotic Focal Therapy industry. It develops, manufactures, and markets minimally invasive medical devices across various countries to treat various conditions using proprietary focused ultrasound technology. The company's flagship platform, Focal One Robotic HIFU, combines imaging, real-time treatment planning, robotic precision, and high intensity focused ultrasound (HIFU) technology. It is focused on expanding the clinical adoption of its patented focused ultrasound-based robotic therapy platforms through continued innovation, clinical evidence generation, physician education, and various market development initiatives.

About ORGO Organogenesis Holdings Inc.

Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.

Share on Social Networks: